Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Review

Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors

Online download statistics by month:

Online download statistics by month: January 2020 to May 2022

	Abstract	Full	Pdf
Jan 2020	8	8	0
Feb 2020	138	138	0
Mar 2020	171	171	12
Apr 2020	249	249	26
May 2020	250	250	29
Jun 2020	94	94	82
Jul 2020	86	86	102
Aug 2020	117	117	88
Sep 2020	131	131	97
Oct 2020	200	200	137
Nov 2020	173	174	123
Dec 2020	163	163	118
Jan 2021	272	272	162
Feb 2021	264	264	116
Mar 2021	341	341	164
Apr 2021	262	262	141
May 2021	339	339	127
Jun 2021	282	283	116
Jul 2021	302	302	164
Aug 2021	287	287	125
Sep 2021	296	296	119
Oct 2021	352	353	175
Nov 2021	327	327	152
Dec 2021	363	370	130
Jan 2022	284	305	126
Feb 2022	400	413	145
Mar 2022	384	407	182
Apr 2022	365	378	122
May 2022	367	386	161
Total	7267	7366	3241